Clinical Trial Update: Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating the combination of vismodegib and atezolizumab in platinum-resistant ovarian, fallopian tube, and primary peritoneal cancers; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Vismodegib (Vismodegib)

Snippet

Sponsor: Ronald Buckanovich | Conditions: Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma | Phase 2 | Status: RECRUITING